Effects of Angiotensin Receptor Blockers on Streptozotocin-Induced Diabetic Cataracts
Journal of Clinical Medicine · 19.10.2023 · 12 (20) · 6627
DOI: 10.3390/jcm12206627 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 19.10.2023. Verfasst von Gaku Ishigooka und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Osaka Medical and Pharmaceutical University, Osaka 569-8686, Japan. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Osaka Eye Bank Association Fund (Osaka, Japan).
Abstract (Originalsprache)
This study aimed to determine the role of oxidative stress produced by the renin–angiotensin system (RAS) in cataract formation in streptozotocin-induced diabetic rats (STZ) using angiotensin II receptor blockers (ARBs). Rats were treated with streptozotocin and orally administered candesartan (2.5 mg/kg/day) or a normal diet for 10 weeks until sacrifice. Cataract progression was assessed through a slit-lamp examination. Animals were euthanized at 18 weeks, and the degree of cataract progression was evaluated. Oxidative stress was also assessed. In STZ-treated rats, lens opacity occurred at 12 weeks. Cataract progression was inhibited in the ARB-treated group compared with the placebo group (p < 0.05). STZ-treated rats exhibited upregulated angiotensin-converting enzyme (ACE) gene expression than control rats. Oxidative stress-related factors were upregulated in the placebo-treated group but suppressed in the ARB-treated group. A correlation coefficient test revealed a positive correlation between ACE gene expression and oxidative stress-related factors and a negative correlation between ACE and superoxide dismutase. Immunostaining revealed oxidative stress-related factors and advanced glycation end products in the lens cortex of the placebo-treated group. The mechanism of diabetic cataracts may be related to RAS, and the increase in focal ACE and angiotensin II in the lens promotes oxidative stress-related factor production.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, Osaka Medical and Pharmaceutical University, Osaka 569-8686, Japan.
- Department of Innovative Medicine, Osaka Medical and Pharmaceutical University, Osaka 569-8686, Japan.
ORCID-Profile: Denan Jin, Shinji Takai, Teruyo Kida
Förderung
- Osaka Eye Bank Association Fund (Osaka, Japan)
Zitieren
APA
Ishigooka, G., Mizuno, H., Oosuka, S., Jin, D., Takai, S., & Kida, T. (2023). Effects of Angiotensin Receptor Blockers on Streptozotocin-Induced Diabetic Cataracts. Journal of Clinical Medicine, 12(20), 6627. https://doi.org/10.3390/jcm12206627
Vancouver
Ishigooka G, Mizuno H, Oosuka S, Jin D, Takai S, Kida T. Effects of Angiotensin Receptor Blockers on Streptozotocin-Induced Diabetic Cataracts. Journal of Clinical Medicine. 2023;12(20):6627. doi:10.3390/jcm12206627
BibTeX
@article{Ishigooka2023,
author = {Ishigooka, Gaku and Mizuno, Hiroshi and Oosuka, Shou and Jin, Denan and Takai, Shinji and Kida, Teruyo},
title = {Effects of Angiotensin Receptor Blockers on Streptozotocin-Induced Diabetic Cataracts},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {12},
number = {20},
pages = {6627},
doi = {10.3390/jcm12206627}
}
EUVIMED